4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-060763
Chief Executive Officer sold 4,400 shares at an average $13.47 ($59,268)
From the SEC's structured data for this filing
Trades in this filing
Ciechanover Isaac E. · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-11-13 | Sale : show line 1 in the form | −2,200 | $13.53 | $29,766 | 421,978 | I |
| 2017-11-14 | Sale : show line 2 in the form | −2,200 | $13.41 | $29,502 | 419,778 | I |
| Open-market sales · 4,400 sh · avg $13.47 · $59,268 | ||||||
Loading xslF345X03/doc4.xml…